Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5617-5620

  Zi, Xiaolin ^a   Zhang, Jianchun ^a   Agarwal, Rajesh ^b   Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FLAVONOID; INSULIN RECEPTOR SUBSTRATE 1; SILIBININ; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; TYROSINE;

ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANDROGENS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOPLASMS, HORMONE-DEPENDENT; PHOSPHOPROTEINS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; SILYMARIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0034667455     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Silybum marianum: Mariendistel
2. Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double-blind, randomized and multicenter trial
3. Milk thistle (Silybum marianum) for the therapy of liver disease
4. Evaluation of potential chemopreventive agents using a mouse epidermal cell line, JB6
5. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents
6. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol
7. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SNCAR mouse skin tumorigenesis model
8. 1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells
9. 1 arrest, leading to differentiation of prostate carcinoma cells: Implication for prostate cancer intervention
10. Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: Inhibition of mRNA expression of an endogenous tumor promotor TNF α
11. 1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins
12. Protective effects of silymarin against photocarcinogenesis in a mouse skin model
13. The role of growth factors in the suppression of active cell death in the prostate: A hypothesis
14. Insulin-like growth factors and prostate cancer
15. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture
16. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
17. Insulin-like growth factor 1: Action and receptor characterization in human prostate cancer cell lines
18. The insulin-like growth factor-binding protein (IGFBP) superfamily
19. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
20. Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
21. Transforming growth factor-β induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
22. 3 and its analog EB1089
23. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells
24. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
25. Bicalutamide [Casodex]-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins
26. Induction of the growth inhibitor IGF-bindind protein 3 by p53
27. Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation
28. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein
29. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
30. Comparative pharmacokinetics of silipide and silymarin in rats
31. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-1, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
32. The IGF-1 receptor in cancer research
33. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
34. Insulin-like growth factor physiology and cancer risk
35. Hormonal predictors of prostate cancer: A meta-analysis